urea has been researched along with ly2183240 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexander, JP; Cravatt, BF | 1 |
Camalli, M; Cascio, MG; Di Marzo, V; Morera, E; Moriello, AS; Nalli, M; Ortar, G | 1 |
Barker, EL; Barrenha, GD; Chester, JA; Mlinac, NS; Powers, MS | 1 |
Garcia-Bereguiain, MA; Gonzalez-Islas, C; Wenner, P | 1 |
Aritake, K; Goda, Y; Kawamura, M; Kikura-Hanajiri, R; Matsuda, S; Shimokawa, Y; Uchiyama, N; Urade, Y | 1 |
Bartusik-Aebisher, D; Florek-Łuszczki, M; Kołodziejczyk, P; Tutka, P; Wlaź, A; Łuszczki, JJ | 1 |
6 other study(ies) available for urea and ly2183240
Article | Year |
---|---|
The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases.
Topics: Amidohydrolases; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Brain; Cannabinoid Receptor Modulators; Carbamates; Cisplatin; Endocannabinoids; Gene Deletion; Heterocyclic Compounds, 1-Ring; Hydrolases; Ifosfamide; Male; Mice; Mice, Inbred C57BL; Mitomycin; Molecular Structure; Urea | 2006 |
Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cell Line, Tumor; Endocannabinoids; Glycerides; Heterocyclic Compounds, 1-Ring; Hydrolysis; Polyunsaturated Alkamides; Rats; Stereoisomerism; Tetrazoles; Urea | 2008 |
Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference.
Topics: Acoustic Stimulation; Alcohol Drinking; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Cannabinoid Receptor Modulators; Comorbidity; Conditioning, Psychological; Disease Models, Animal; Endocannabinoids; Ethanol; Female; Heterocyclic Compounds, 1-Ring; Male; Mice; Motor Activity; Reflex, Startle; Reward; Time Factors; Urea | 2010 |
Tonic and transient endocannabinoid regulation of AMPAergic miniature postsynaptic currents and homeostatic plasticity in embryonic motor networks.
Topics: Age Factors; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analgesics; Animals; Arachidonic Acids; Benzoxazines; Chick Embryo; Electric Stimulation; Endocannabinoids; Excitatory Amino Acid Agonists; Female; gamma-Aminobutyric Acid; Heterocyclic Compounds, 1-Ring; Homeostasis; Male; Morpholines; Motor Neurons; Naphthalenes; Nerve Net; Neuronal Plasticity; Patch-Clamp Techniques; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Signal Transduction; Spinal Cord; Synaptic Potentials; Urea | 2012 |
Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products.
Topics: Alkaloids; Cannabinoids; Central Nervous System Stimulants; Designer Drugs; Heterocyclic Compounds, 1-Ring; Japan; Legislation, Drug; Methylphenidate; Plant Preparations; Psychotropic Drugs; Substance-Related Disorders; Urea | 2014 |
Arvanil, olvanil, AM 1172 and LY 2183240 (various cannabinoid CB1 receptor agonists) increase the threshold for maximal electroshock-induced seizures in mice.
Topics: Animals; Arachidonic Acids; Benzamides; Brain; Brain Waves; Cannabinoid Receptor Agonists; Capsaicin; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Heterocyclic Compounds, 1-Ring; Male; Mice; Receptor, Cannabinoid, CB1; Seizures; Signal Transduction; Urea | 2018 |